|
Market Closed -
Nasdaq
21:00:00 26/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 88.96 USD | -0.22% |
|
-1.02% | +34.04% |
| 08-24 | Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing | MT |
| 08-13 | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 94.12 | +5.8% | 25 | ||||||
| 120.2 | +5.35% | 25 | ||||||
| 97.92 | +6.41% | 25 | ||||||
| 369.31 | +12.67% | 13 | ||||||
| 30,666.67 | +22.84% | 15 | ||||||
| 194.42 | +2.21% | 12 | ||||||
| 44.62 | +29.02% | 26 | ||||||
| 404.73 | +15.66% | 15 | ||||||
| 3,133.08 | +21.81% | 13 | ||||||
| 263.12 | +11.13% | 8 | ||||||
| 232.64 | +21.17% | 14 | ||||||
| 107.57 | +6.11% | 21 | ||||||
| 42.95 | -3.84% | 11 | ||||||
| 93.92 | +2.61% | 13 | ||||||
| 28.73 | +8.4% | 11 | ||||||
| 208.6 | +31.08% | 15 | ||||||
| 103.23 | +24.22% | 13 | ||||||
| 329 | -15.35% | 5 | ||||||
| 185.7 | +3% | 20 | ||||||
| 171.91 | +19.9% | 22 | ||||||
| Average | 1,844.62 | +11.51% | 16 | ||||||
| Weighted average by Cap. | 2,367.96 | +9.94% | 19 |
- Stock Market
- Stocks
- DXCM Stock
- Sector DexCom, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
